Extrawell Pharmaceutical Holdings Limited
HKSE: 0858.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi Guo
- Employees
- 162
- Headquarters
- Quarry Bay, Hong Kong SAR China
- IPO year
- 1999
- Market cap
- HK$160.3M
- Website
- https://www.extrawell.com.hk
Loading 0858…
Loading profile data…Frequently asked questions about 0858
What does Extrawell Pharmaceutical Holdings Limited (0858.HK) do?
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the t...
Where does 0858.HK trade?
Extrawell Pharmaceutical Holdings Limited (0858.HK) trades on the Hong Kong Stock Exchange.
What sector is 0858.HK in?
Extrawell Pharmaceutical Holdings Limited (0858.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Extrawell Pharmaceutical Holdings Limited?
Yi Guo is the chief executive officer of Extrawell Pharmaceutical Holdings Limited (0858.HK).
Where is Extrawell Pharmaceutical Holdings Limited headquartered?
Extrawell Pharmaceutical Holdings Limited is headquartered in Hong Kong SAR China.
Does 0858.HK pay a dividend?
Extrawell Pharmaceutical Holdings Limited (0858.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0858.HK go public?
Extrawell Pharmaceutical Holdings Limited (0858.HK) completed its initial public offering in 1999.